| Identification | |
| Name: | Fosaprepitant |
| Synonyms: | Phosphonicacid,[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-(9CI);Phosphonic acid,[3-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-,[2R-[2a(R*),3a]]-;Phosphonic acid,P-[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-;L 758298; |
| CAS: | 172673-20-0 |
| Molecular Formula: | C23H22F7N4O6P |
| Molecular Weight: | 614.41 |
| InChI: | InChI=1/C23H22F7N4O6P/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)40-20-19(13-2-4-17(24)5-3-13)33(6-7-39-20)11-18-31-21(35)34(32-18)41(36,37)38/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H,31,32,35)(H2,36,37,38)/t12-,19+,20-/m1/s1 |
| Molecular Structure: | ![(C23H22F7N4O6P) Phosphonicacid,[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-m...](https://img1.guidechem.com/chem/e/dict/120/172673-20-0.jpg) |
| Properties | |
| Density: | 1.65 g/cm3 |
| Refractive index: | 1.589 |
| Specification: |
?Fosaprepitant (CAS NO.172673-20-0) is also named as L-758,298 ; L-758298 ; UNII-6L8OF9XRDC?; Phosphonic acid, (3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl)- ; Phosphonic acid, (3-((2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl)-, (2R-(2alpha(R*),3alpha))- .?Fosaprepitant (CAS NO.172673-20-0) is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. |
| Safety Data | |
 |
|
